Review



human male diploid lung wi 26 sv40 fibroblasts  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    ATCC human male diploid lung wi 26 sv40 fibroblasts
    Human Male Diploid Lung Wi 26 Sv40 Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 98 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human male diploid lung wi 26 sv40 fibroblasts/product/ATCC
    Average 94 stars, based on 98 article reviews
    human male diploid lung wi 26 sv40 fibroblasts - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    human male diploid lung wi 26 sv40 fibroblasts  (ATCC)
    94
    ATCC human male diploid lung wi 26 sv40 fibroblasts
    Human Male Diploid Lung Wi 26 Sv40 Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human male diploid lung wi 26 sv40 fibroblasts/product/ATCC
    Average 94 stars, based on 1 article reviews
    human male diploid lung wi 26 sv40 fibroblasts - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    human diploid lung fibroblast  (ATCC)
    99
    ATCC human diploid lung fibroblast
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Human Diploid Lung Fibroblast, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human diploid lung fibroblast/product/ATCC
    Average 99 stars, based on 1 article reviews
    human diploid lung fibroblast - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    consent human diploid lung fibroblast cell line mrc 5  (ATCC)
    99
    ATCC consent human diploid lung fibroblast cell line mrc 5
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Consent Human Diploid Lung Fibroblast Cell Line Mrc 5, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/consent human diploid lung fibroblast cell line mrc 5/product/ATCC
    Average 99 stars, based on 1 article reviews
    consent human diploid lung fibroblast cell line mrc 5 - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    human diploid lung fibroblast cell line mrc 5  (ATCC)
    99
    ATCC human diploid lung fibroblast cell line mrc 5
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Human Diploid Lung Fibroblast Cell Line Mrc 5, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human diploid lung fibroblast cell line mrc 5/product/ATCC
    Average 99 stars, based on 1 article reviews
    human diploid lung fibroblast cell line mrc 5 - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    human lung diploid fibroblasts imr 90  (ATCC)
    99
    ATCC human lung diploid fibroblasts imr 90
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Human Lung Diploid Fibroblasts Imr 90, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung diploid fibroblasts imr 90/product/ATCC
    Average 99 stars, based on 1 article reviews
    human lung diploid fibroblasts imr 90 - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    imr90 primary human diploid lung embryonic fibroblasts  (ATCC)
    99
    ATCC imr90 primary human diploid lung embryonic fibroblasts
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Imr90 Primary Human Diploid Lung Embryonic Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/imr90 primary human diploid lung embryonic fibroblasts/product/ATCC
    Average 99 stars, based on 1 article reviews
    imr90 primary human diploid lung embryonic fibroblasts - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    human embryonic lung diploid fibroblasts (2bs)  (China Center for Type Culture Collection)
    90
    China Center for Type Culture Collection human embryonic lung diploid fibroblasts (2bs)
    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung <t>fibroblasts</t> (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.
    Human Embryonic Lung Diploid Fibroblasts (2bs), supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic lung diploid fibroblasts (2bs)/product/China Center for Type Culture Collection
    Average 90 stars, based on 1 article reviews
    human embryonic lung diploid fibroblasts (2bs) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung fibroblasts (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.

    Journal: bioRxiv

    Article Title: FOXO3 regulated MIR503HG safeguards cellular quiescence by modulating PI3K/Akt pathway via miR-508/PTEN axis

    doi: 10.64898/2026.03.27.714688

    Figure Lengend Snippet: (A) Schematic representation of establishment of cellular quiescence induction model. (B) PI-Flow cytometry analysis of asynchronous and quiescent human diploid lung fibroblasts (WI38). (C) Quantitative representation of percentage cell population at each stage in asynchronous and quiescent WI38 cells. (D) RNA levels of MIR503HG, HES1, MXI1 and p53 examined by qRT-PCR in asynchronous, G0 and serum stimulated cells. (E) qRT-PCR analysis of MIR503HG RNA in control (scr) and MIR503HG depleted cells (MIR503HG-ASO) using antisense oligos. (F) PI-Flow cytometry analysis of WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) Quantitative representation of percentage cell population at each stage in control and MIR503HG depleted cells. (H) Cell cycle profile of asynchronous HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing G0 and G1 populations using Hoechst-pyronin staining. (I) Cell cycle profile of serum starved quiescent HeLa cells treated with scr-oligo and MIR503HG-ASO distinguishing different cell populations using Hoechst-pyronin staining. (J) qRT-PCR analysis of quiescent markers HES1, MXI1 and p53 in asynchronous and quiescent cells treated with scr-oligo and MIR503HG-ASO. *: p≤0.05, **: p≤ 0.01, ***: p ≤0.001, ****: p ≤0.0001, ns: p> 0.05 by two-tailed student’s t-test, n=3. Error bars represent standard deviation.

    Article Snippet: The normal human diploid lung fibroblast, WI-38 (American Type Culture Collection, Cat no-ATCC-CCL-75) was cultured in Minimum Essential Medium (MEM)(GIBCO) supplemented with 10% FBS (GIBCO), 0.1% Non-essential amino acids (MP Biomedicals), 0.1% Penicillin-Streptomycin (GIBCO) at 37°C with 95% relative humidity and 5% CO2.

    Techniques: Flow Cytometry, Quantitative RT-PCR, Control, Staining, Two Tailed Test, Standard Deviation

    (A) qRT-PCR analysis of MIR503HG, HES1 and SALL2 RNA in asynchronous and G0 NHDFs (Normal human dermal fibroblasts). (B) qRT-PCR analysis of MIR503HG in asynchronous and G0 Hela, HCT116, U2OS and MCF7 cells. (C, D) Subcellular fractionation followed by qRT-PCR analysis for MIR503HG, MALAT1 and RNR in asynchronous and quiescent WI38 cells. (E) PI-Flow cytometry analysis of asynchronous and quiescent WI38 cells treated with scr-oligo and MIR503HG-ASO. (F) Quantitative representation of percentage cell population from PI-Flow cytometry analysis of asynchronous and quiescent WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) qRT-PCR analysis for miR503 in G0 control and MIR503HG depleted cells. (H) PI-Flow cytometry analysis of asynchronous, quiescent and WI38 cells treated with miR503 inhibitor.

    Journal: bioRxiv

    Article Title: FOXO3 regulated MIR503HG safeguards cellular quiescence by modulating PI3K/Akt pathway via miR-508/PTEN axis

    doi: 10.64898/2026.03.27.714688

    Figure Lengend Snippet: (A) qRT-PCR analysis of MIR503HG, HES1 and SALL2 RNA in asynchronous and G0 NHDFs (Normal human dermal fibroblasts). (B) qRT-PCR analysis of MIR503HG in asynchronous and G0 Hela, HCT116, U2OS and MCF7 cells. (C, D) Subcellular fractionation followed by qRT-PCR analysis for MIR503HG, MALAT1 and RNR in asynchronous and quiescent WI38 cells. (E) PI-Flow cytometry analysis of asynchronous and quiescent WI38 cells treated with scr-oligo and MIR503HG-ASO. (F) Quantitative representation of percentage cell population from PI-Flow cytometry analysis of asynchronous and quiescent WI38 cells treated with scr-oligo and MIR503HG-ASO. (G) qRT-PCR analysis for miR503 in G0 control and MIR503HG depleted cells. (H) PI-Flow cytometry analysis of asynchronous, quiescent and WI38 cells treated with miR503 inhibitor.

    Article Snippet: The normal human diploid lung fibroblast, WI-38 (American Type Culture Collection, Cat no-ATCC-CCL-75) was cultured in Minimum Essential Medium (MEM)(GIBCO) supplemented with 10% FBS (GIBCO), 0.1% Non-essential amino acids (MP Biomedicals), 0.1% Penicillin-Streptomycin (GIBCO) at 37°C with 95% relative humidity and 5% CO2.

    Techniques: Quantitative RT-PCR, Fractionation, Flow Cytometry, Control